Clinical Trials Logo

Endogenous Anterior Uveitis clinical trials

View clinical trials related to Endogenous Anterior Uveitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01201798 Completed - Clinical trials for Endogenous Anterior Uveitis

Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis

Start date: October 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of endogenous anterior uveitis.